Episurf announced achievement of the 150th implant of the Episealer® knee system, a patient-specific approach to the treatment of focal cartilage lesions. The milestone occurs less than six months after its 100th case.
Procedures begin with the Epioscopy® process to visualize and assess cartilage damage, thus enabling an implant to be tailored to a patient’s specific anatomy and pathology. This damage assessment tool received CE Mark approval at the beginning of 2016.
Sources: Episurf Medical AB; ORTHOWORLD Inc.